Back

Gene regulatory co-expression networks decipher potential lncRNA-miRNA-mRNA interactions modulating transcription regulation in neurodegeneration

Venkatesan, A.; Sinha, P.; Basak, J.; Bahadur, R.

2026-07-08 bioinformatics
10.64898/2026.07.03.736295 bioRxiv
Show abstract

Neurodegenerative diseases are complex disorders characterised by progressive neuronal loss and widespread transcriptomic dysregulation; however, the coordinated interactions among coding and non-coding RNAs that contribute to disease progression remain incompletely understood. In this study, RNA-seq datasets from disease-relevant neuronal populations and brain regions representing Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS) were analysed using an integrative network-based framework. Differential expression analysis coupled with weighted gene co-expression network analysis identified modules significantly correlated with disease and prioritised highly connected hub genes. Integration of these hub genes with curated RNA interaction database enabled the construction of candidate lncRNA-miRNA-mRNA regulatory networks. Functional enrichment analysis revealed Gene Ontology biological processes associated with synaptic signalling, mitochondrial function, RNA metabolism and neuroinflammatory responses across neurodegenerative conditions. The inferred regulatory networks suggested both disease-specific and shared post-transcriptional regulatory modules involving key hub genes and non-coding RNAs. Additionally, putative sequence variants were identified within untranslated regions of selected hub genes, suggesting potential alterations in miRNA-mediated regulations. Therefore, this study provides a systems-level view of transcriptomic dysregulation across major neurodegenerative diseases and identifies candidate regulatory interactions and molecular targets for future functional investigation

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3612 papers in training set
Top 5%
9.8%
2
International Journal of Molecular Sciences
494 papers in training set
Top 0.5%
7.9%
3
PLOS ONE
5266 papers in training set
Top 22%
7.9%
4
NAR Molecular Medicine
22 papers in training set
Top 0.1%
6.7%
5
Acta Neuropathologica Communications
89 papers in training set
Top 0.4%
5.5%
6
Frontiers in Genetics
230 papers in training set
Top 0.7%
4.3%
7
Genes
144 papers in training set
Top 0.7%
3.5%
8
BMC Genomics
406 papers in training set
Top 2%
3.2%
9
Genomics, Proteomics & Bioinformatics
16 papers in training set
Top 0.1%
3.2%
50% of probability mass above
10
Briefings in Bioinformatics
354 papers in training set
Top 3%
3.2%
11
Computational and Structural Biotechnology Journal
242 papers in training set
Top 2%
2.8%
12
Nature Communications
5641 papers in training set
Top 42%
2.1%
13
RNA Biology
78 papers in training set
Top 0.6%
1.9%
14
Molecular Therapy Nucleic Acids
39 papers in training set
Top 0.5%
1.7%
15
Genome Research
468 papers in training set
Top 4%
1.7%
16
Nucleic Acids Research
1281 papers in training set
Top 10%
1.5%
17
ACS Omega
105 papers in training set
Top 2%
1.5%
18
Communications Biology
993 papers in training set
Top 19%
1.3%
19
npj Genomic Medicine
36 papers in training set
Top 0.5%
1.3%
20
Neurobiology of Disease
148 papers in training set
Top 3%
1.1%
21
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
26 papers in training set
Top 0.6%
1.0%
22
iScience
1154 papers in training set
Top 31%
1.0%
23
npj Systems Biology and Applications
125 papers in training set
Top 2%
0.9%
24
Biomedicines
67 papers in training set
Top 3%
0.8%
25
Neurobiology of Aging
107 papers in training set
Top 1%
0.8%
26
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 5%
0.8%
27
International Journal of Biological Sciences
10 papers in training set
Top 0.1%
0.8%
28
NAR Genomics and Bioinformatics
242 papers in training set
Top 4%
0.8%
29
Journal of Alzheimer’s Disease
50 papers in training set
Top 1%
0.8%
30
Molecular Omics
23 papers in training set
Top 0.5%
0.6%